Akums Drugs and Pharmaceuticals Limited (NSE:AKUMS)

India · Delayed Price · Currency is INR

520.80

-0.55 (-0.11%)

May 22, 2026, 3:30 PM IST

Revenue by Segment

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
CDMO	37.10B	34.40B	36.20B	31.21B	29.78B
CDMO Growth	7.85%	-4.96%	15.99%	4.80%	24.04%
API	2.31B	2.77B	2.78B	2.22B	1.36B
API Growth	-16.50%	-0.47%	25.26%	63.33%	20151.19%
Domestic Branded Formulations	4.46B	4.34B	3.98B	-	-
Domestic Branded Formulations Growth	2.93%	8.81%	-	-	-
International Branded Formulations	1.43B	1.43B	1.25B	-	-
International Branded Formulations Growth	0.60%	14.26%	-	-	-
Trade Generics	1.00B	1.18B	1.77B	-	-
Trade Generics Growth	-14.89%	-33.27%	-	-	-
Inter-Segment	-2.73B	-2.93B	-4.20B	-4.43B	-3.45B
Branded and Generic Formulations	-	-	-	7.55B	9.03B
Branded and Generic Formulations Growth	-	-	-	-16.39%	54.21%
Total	43.59B	41.18B	41.78B	36.55B	36.72B
Total Growth	5.85%	-1.44%	14.32%	-0.46%	34.87%

Revenue by Geography

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
India	43.59B	41.21B	41.82B	36.57B	36.75B
India Growth	5.77%	-1.45%	14.34%	-0.49%	34.81%
Total	43.59B	41.21B	41.82B	36.57B	36.75B
Total Growth	5.77%	-1.45%	14.34%	-0.49%	34.81%

Source: S&P Global Market Intelligence.